Search Tag: Merck

Cardiology Management

BREAKING NEWS: COVID-19 Pill Receives First Authorisation in the World

2021 04 Nov

U.K.’s Medicines and Healthcare Products Regulatory Agency has authorised the first oral antiviral medicine for treating mild-to-moderate COVID-19 in adults with a positive COVID-19 infection and at least one risk factor for developing severe illness.    Molnupiravir will be the first oral medicine authorised for COVID-19. This is a major achievement... Read more

Pharmacy Management

Merck Obtains Rights To Ebola Vaccine

2014 26 Nov

Merck & Co. has obtained the rights to an experimental Ebola vaccine. The vaccine has been developed by NewLink Genetics Corp. According to reports, Merck will be paying NewLink $30 million upfront plus an additional $20 million when clinical trials get under way. NewLink originally obtained this vaccine in 2010 from Canadian officials for $200,000.... Read more